FDA tightens rules on clinical investigator disqualification

The FDA has issued a final rule to stiffen regulations on disqualifying clinical researchers from medical device and drug studies. The revised rule, which will take effect May 30, is intended to make sure that clinical researchers who have been disqualified from conducting trials involving medical devices do not engage in research concerning drugs or vice versa.

View Full Article in:

Clinica - US FDA finalises stricter rules on disqualifying clinical investigators in drug, device studies - Clinica (subscripti

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN